Skip to content
Research Article Open access CC BY 4.0

Incidence of Candidiasis and Associated Risk in Diabetic Patients

Michael Unata Iduh, Seyi Samson Enitan, Asiya Umar Imam, Nura Muhammad Bunza, Abdurrahman Mahmoud

International Journal of Pathogen Research · pp. 12–22 · Published 2 Sep 2024

10.9734/ijpr/2024/v13i5305

Abstract

Candida causes candidiasis. The genus Candida contains about 200 different species, but only a small proportion of Candida are dangerous and cause more external or internal diseases when they enter the body. Candida albicans is a ubiquitous pathogen, associated with many bacteria in the mouth, throat, and intestines. The immune system and the bacteria present are monitored for Candida, and damage to the immune system or changes in the bacteria can cause Candida to become infected. In general, these infections are limited to the mouth, genital area, and skin, but people with cancer or other serious diseases, such as HIV, have very weak immune systems which make them suffer from more serious diseases.

Candida albicans diabetes mellitus gastrointestinal tract yeast

References (39)

  1. 1 Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications [DOI]
  2. 2 Candida biofilms and their role in infection [DOI]
  3. 3 Candidalysin is a fungal peptide toxin critical for mucosal infection [DOI]
  4. 4 Adherence and biofilm formation of non-Candida albicans Candida species [DOI]
  5. 5 Candida Species Biofilms’ Antifungal Resistance [DOI]
  6. 6 High rate of non-albicans candidemia in Brazilian tertiary care hospitals [DOI]
  7. 7 Prediabetes and associated disorders [DOI]
  8. 8 Differences in the gut microbiota of healthy children and those with type 1 diabetes [DOI]
  9. 9 Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole [DOI]
  10. 10 Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors [DOI]
  11. 11 Candidal overgrowth in diabetic patients: potential predisposing factors [DOI]
  12. 12 Risk Factors for Candida Vulvovaginitis [DOI]
  13. 13 Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - a pilot study [DOI]
  14. 14 Complicated urinary tract infections associated with diabetes mellitus: Pathogenesis, diagnosis and management [DOI]
  15. 15 The prevalence of oral Candida infections in periodontitis patients with type 2 diabetes mellitus [DOI]
  16. 16 Epidemiology and predictors of a poor outcome in elderly patients with candidemia [DOI]
  17. 17 Severe Candida spp. infections: new insights into natural immunity [DOI]
  18. 18 The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study [DOI]
  19. 19 New perspectives on the nutritional factors influencing growth rate of Candida albicans in diabetics. An in vitro study [DOI]
  20. 20 Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital [DOI]
  21. 21 Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors [DOI]
  22. 22 Candida Carriage Rate and Growth Characteristics of Saliva in Diabetes Mellitus Patients: A Case‒Control Study [DOI]
  23. 23 Invasive candidiasis and candidemia: new guidelines.
  24. 24 Vulvovaginal Candidiasis and its Related Factors in Diabetic Women [DOI]
  25. 25 Epidemiology and prognostic factors of candidemia in elderly patients [DOI]
  26. 26 Characterization and identification of candiduria due to Candida species in diabetic patients [DOI]
  27. 27 Prevalence of candiduria in diabetic patients attending Gondar University Hospital, Gondar, Ethiopia.
  28. 28 Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis [DOI]
  29. 29 Comparative Study of Esterase and Hemolytic Activities in Clinically Important Candida Species, Isolated From Oral Cavity of Diabetic and Non-diabetic Individuals [DOI]
  30. 30 Coordination of Candida albicans Invasion and Infection Functions by Phosphoglycerol Phosphatase Rhr2 [DOI]
  31. 31 Identification, antifungal resistance profile, in vitro biofilm formation and ultrastructural characteristics of Candida species isolated from diabetic foot patients in Northern India [DOI]
  32. 32 Yeast Infection and Diabetes Mellitus among Pregnant Mother in Malaysia.
  33. 33 Phenotypic switch: The enigmatic white-gray-opaque transition system of Candida albicans [DOI]
  34. 34 Hemolytic activity and production of germ tubes related to pathogenic potential of clinical isolates of Candida albicans
  35. 35 Activation of the plasma kallikrein-kinin system by Candida albicans proteinase [DOI]
  36. 36 In vitro antifungal susceptibility of Candida speciesisolated from diabetic patients [DOI]
  37. 37 Candida Species – Morphology, Medical Aspects And Pathogenic Spectrum
  38. 38 High Interleukin-12 Levels May Prevent an Increase in the Amount of Fungi in the Gastrointestinal Tract during the First Years of Diabetes Mellitus Type 1 [DOI]
  39. 39 Current Trends in Candidemia and Species Distribution Among Adults: Candida glabrata Surpasses C. albicans in Diabetic Patients and Abdominal Sources. [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

54

Page views

0

PDF downloads

16

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.